POLITICO @politico
The approval of an expensive new Alzheimer’s therapy would seem like the perfect candidate for inflaming Washington’s debate over prescription drug prices. But hardly anybody on Capitol Hill is talking about it https://t.co/jdJQ1bfpyu — PolitiTweet.org